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Treatment of choice in patients with unilateral aldosterone producing adenoma (APA) is 
adrenalectomy. Following surgery, most patients retain normal adrenal function, while some 
develop adrenal insufficiency (AI). To facilitate early detection and treatment of AI, we aimed to 
identify variables measured pre-operatively that are associated with post-operative AI. Variables 
obtained from 66 patients before and after surgery included anthropometrical data, clinical 
chemistry, endocrine work-up. LC–MS/MS steroid hormone profiles from tests before surgery (ACTH-
stimulation, saline infusion, dexamethasone suppression) were obtained. Based on 78 variables, 
machine-learning methods were used in model fitting for classification and regression to predict 
ACTH-stimulated cortisol after surgery. Among the 78 variables, insulin concentration during pre-
operative oral glucose tolerance test (OGTT) correlated positively, and dexamethasone suppressed 
glucocorticoids correlated negatively with ACTH-stimulated cortisol after surgery. Inclusion of LC–MS/
MS measurements allowed construction of better models associated with the occurrence of AI in 
the training data, but did not allow reliable prediction in cross-validation. Our results suggest that 
glucocorticoid co-secretion (low insulin during pre-operative OGTT and insufficient suppression of 
glucocorticoids following dexamethasone) are correlated with the development of post-operative AI. 
Addition of steroid profiles improved the accuracy of prediction, but cross validation revealed lack of 
reliability in the prediction of AI.
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LC–MS/MS  Liquid chromatography with tandem mass spectrometry
LOOCV  Leave-one-out cross validation
LoQs  Limits of quantifications
MAE  Mean absolute error
MSE  Mean squared error
OGTT  Oral glucose tolerance test
PA  Primary aldosteronism
SIT  Saline infusion test
SPE  Solid phase extraction
Primary aldosteronism (PA) is an adrenal disease characterized by inappropriate autonomous production of 
aldosterone and consecutively suppressed renin  concentrations1–4. The prevalence of PA ranges between 5 and 
15% in the general hypertensive population and between 14 and 21% in resistant hypertension,  respectively5, 6. 
Today, PA is considered the leading cause of secondary hypertension that can be cured by  surgery7. Early diag-
nosis and treatment are important, since PA patients have a higher risk of cardiovascular events and target organ 
damage than normal  hypertensives8–10. Aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia 
(BAH) are the two most common forms of  PA11, accounting for 40% and 60% of the cases,  respectively12. Thera-
peutic options differ depending on the subtype. Targeted medical treatment with mineralocorticoid receptor 
antagonists (MRA) is used in patients with BAH, while surgical removal of the aldosterone producing tumor 
by laparoscopic unilateral adrenalectomy is recommended in patients with unilateral  disease13, 14. After sur-
gery, most patients with APAs achieve complete or partial biochemical remission, and improvements in blood 
pressure  control15. However, besides the intended reduction in mineralocorticoids, in some patients unilateral 
adrenalectomy results in impaired glucocorticoid  secretion16.
We recently have reported prevalence and clinical characteristics of insufficient glucocorticoid production in 
a subgroup of APA patients following unilateral adrenalectomy, resulting in transient or even prolonged adrenal 
insufficiency (AI) and rarely to a life-threatening adrenal crisis. As reported recently, twenty-seven percent of the 
cohort developed postoperative AI, while those with severe AI (stimulated cortisol < 13.5 µg/dL) needed signifi-
cantly longer hydrocortisone replacement therapy than those who were classified to have moderate AI (stimulated 
cortisol 13.5 to 17 µg/dL) (median in days (25th, 75th percentile): severe AI: 353 (294, 476) vs moderate AI: 74 
(32, 293); p = 0.016)17. A likely reason for the occurrence lays in the fact that some APAs also co-secrete glucocor-
ticoids, leading to minimal suppression of pituitary ACTH secretion and thereby, glucocorticoid production from 
the contralateral  adrenal18. Consequently, after surgical removal of the APA, the suppressed contralateral adrenal 
would be unable to produce sufficient glucocorticoids until the recovery of the hypothalamic–pituitary–adrenal 
axis. Since late diagnosis or unawareness of AI would potentially endanger patients, early identification of those 
at risk to develop AI is desirable. However, in our recently published study we could not identify clinical or bio-
chemical variables allowing to preoperatively predict the risk to develop AI after  surgery17. Our hypothesis for 
the present study was that extending standard biochemical testing by dynamic endocrine tests combined with 
LC–MS/MS-based steroid profiling would allow us to better characterize the adrenal capacity of the patients, 
and thereby to predict the individual risk for development of AI following adrenalectomy. Indeed, LC–MS/MS 
based steroid profiling has recently been demonstrated to be useful in identification of subtypes of  PA19–22. Our 
objectives were (a) to identify variables before surgery that correlate to cortisol production after surgery; (b) to 
determine the utility of LC–MS/MS steroid profiling before surgery to predict AI after surgery; and (c) to cross-
validate the performance of a prediction model established based on our data.
Results
Single variable analysis. We identified 9 out of 78 variables collected before surgery which exhibited sta-
tistically significant (a = 0.05) correlation with stimulated cortisol after surgery. Two of the variables were cor-
tisol measured by immunoassay at distinct time points (pre-operative ACTH stimulated cortisol (Fig. 1B) and 
salivary cortisol at 20:00). Three variables were steroids measured by LC–MS/MS (baseline estradiol (Fig. 1C), 
corticosterone (Fig. 1D) and 21-deoxycortisol following dexamethasone suppression). The other four variables 
were related to glucose metabolism: glucose and insulin at 60 min (Fig. 1A) as well as insulin at 120 min during 
OGTT and hemoglobin A1C (Hba1c). Notably, age was not correlated to stimulated cortisol after surgery, but 
higher estradiol values correlated with lower post-operative stimulated cortisol values as 61% of AI patients were 
females. In order to further confirm the significance of the correlations observed, we adjusted the significance 
level for the number of variables (a = 0.05/78 variables) to avoid accumulation of false positive rejections of the 
null hypothesis. After this correction, insulin at 60 min during OGTT still significantly correlated with ACTH 
stimulated cortisol after surgery (Fig. 1A).
Comparing patients from the sAI and AS groups, a significant difference between the groups was observed 
for 4 variables: salivary cortisol at 20:00 (sAI (mean (SD): 2.988 (1.802) ng/mL vs. AS 1.7102 (0.977) ng/mL, 
p = 0.0452, Fig. 2B), dexamethasone suppressed corticosterone (sAI (mean (SD): 1.42 (0.28) ng/mL vs. AS 1.29 
(0.22) ng/mL, p = 0.0264, Fig. 2C), insulin at 60 min during OGTT (sAI (mean (SD): 33.55 (7.72) μIU/mL vs. AS 
67.65 (55.03) μIU/mL, p = 0.0349, Fig. 2A), and baseline HbA1c (sAI (mean (SD): 4.95 (0.41) % vs. AS 5.38 (0.56) 
%, p = 0.0212). ROC analysis showed area under the curve (AUC) values of 0.738 for insulin at 60 min and 0.709 
for HbA1c, supporting their ability to distinguish between sAI and AS groups. HOMA-IR and HOMA-ß were 
calculated for the patient cohort. sAI patients showed a tendency towards lower HOMA-ß and higher HOMA-IR 
values in comparison to the AS group, although the difference did not reach statistical significance. Median and 
interquartile range of all variables in the three groups are provided in Supplement Table S2.
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Multiple-variable analyses. In order to investigate associations between preoperative variables and the 
occurrence of postoperative AI, we built linear regression models with the significant variables that we found in 
the single variable analysis. As mentioned above, nine variables fell into this category. Of those, two could not be 
used because more than 20% of the data were missing for steroid measurements by LC–MS/MS after dexametha-
sone suppression test (most were undetectably low). From the remaining seven variables, we excluded another 
three because they had no significant contribution to the model. The remaining four variables were insulin 
during OGTT at 60 min, salivary cortisol at 20:00, baseline cortisone and baseline estradiol during ACTH test. 
According to standard coefficients (Table 1), the strength of the effects was highest for insulin during OGTT at 
60 min, followed by salivary cortisol at 20:00, baseline cortisone and baseline estradiol. The R squared between 
the true and the predicted value in LOOCV was 0.2185 (MAE 4.80, MSE 39.11, Fig. 3B). Leaving out data from 
LC–MS/MS measurements and using only insulin at 60 min during OGTT and salivary cortisol at 20:00 led to 
a further drop in R squared between the true and the predicted values in LOOCV to 0.1854 (MAE 4.96, MSE 
39.89 (Fig. 3A)). The associations between the predicted values from the linear regression model and the true 
values can be seen in Fig. 3B.
As mentioned above, the other 69 variables recorded before surgery had no significant correlation to outcome 
as a single variable. We next explored if a combination of multiple variables could improve prediction and applied 
machine learning methods. Due to our limited sample size and the large amount of variables, we mainly used 
the methods with embedded feature selection, such as tree-based methods and regressions with regularization. 
7 different statistical methods, namely lasso regression, ridge  regression23, 24, random  forest25, decision  tree26, 
model-based  boosting27, gradient tree  boosting28 and  xgboost29, were performed to identify the best model. We 
integrated cross validation (LOOCV) to evaluate the predictive capacity of each model established by the training 
Figure 1.  Single variables correlating with post-operative stimulated cortisol. Pre-operative insulin at 60 min 
during oral glucose tolerance test (OGTT) is positively correlated with post-operative stimulated cortisol (A). 
Pre-operative stimulated cortisol is positively correlated with post-operative stimulated cortisol (B). Pre-
operative ACTH test baseline estradiol is negatively correlated with post-operative stimulated cortisol (C). 
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data on a new observation. In the following, we only report analyses using xgboost and model-based boosting 
since these methods outperformed the others by far.
Classification of patients regarding adrenal insufficiency and sufficiency. For classification analysis, we combined 
mAI and sAI patients into one “AI group” (n = 13, eight females and five males) and compared this group to the 
AS group (n = 53, 28 females, 25 males). Without the 15 steroid hormones measured by LC–MS/MS on two 
occasions included in the variables, xgboost correctly classified 100% of AS patients and 92.3% (12 out of 13) of 
AI patients by 33 variables (e.g. age, insulin at 60 min during OGTT and salivary cortisol at 20:00) in training 
data (Fig. 2D). Adding the steroid profiles and using all 63 variables, 100% patients were correctly classified into 
both groups in the training data (Fig. 2E). However, the majority of AI patients were misclassified in cross valida-
tion (Fig. 2F,G). Therefore, the xgboost models seem to exhibit over-fitting to the training data.
Figure 2.  Boxplots of differences between severe AI and adrenal sufficiency groups in individual variable 
(A–C); the classification of gradient tree boosting model in training data (D,E) and cross validation (F,G). 
*Represent p value smaller than 0.05, namely significant difference. Boxplot of pre-operative insulin at 
60 min during oral glucose tolerance test (OGTT) (A). Boxplot of salivary cortisol at 20:00 (B). Boxplot of 
dexamethasone suppressed corticosterone (C).
Table 1.  Coefficients, standard coefficients and p-values of coefficients of each variable in the linear regression 
model. *p-value <0.05; ***p-value < 0.001.
Coefficients Standard coefficients p-value (coefficients)
(Intercept) 16.38388 6.709e−17 1.0000
Insulin at 60 min during OGTT 0.06450 4.444e−01 7.39e−05***
Salivary cortisol at 20:00  − 1.38434  − 2.339e−01 0.0282*
Cortisone ACTH test baseline 0.27062 2.332e−01 0.0291*
Estradiol ACTH test baseline  − 29.65508  − 2.266e−01 0.0322*
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Prediction of ACTH stimulated cortisol after surgery. To further evaluate if the combination of variables obtained 
before surgery can be used to reliably predict adrenal status after surgery, we applied the 7 statistical methods 
that were mentioned above. Regression model-based boosting achieved the best results in the training data. 
Without the 30 LC–MS/MS based variables, the adjusted R-squared between the true and the predicted values in 
training data was 0.7066 (mean absolute error (MAE) 3.38; mean squared error (MSE) 17.25 (Fig. 4A)). When 
the 30 variables from LC–MS/MS based steroid measurements were included, the adjusted R-squared increased 
to 0.7979 (MAE 2.90; MSE 13.02 (Fig. 4B)). Analysis of the importance of the individual variables for the model 
by permutation (Fig. 4C) revealed that insulin at 60 min during OGTT was the most important feature in the 
model, followed by baseline cortisone and baseline DHEAS during ACTH test.
In contrast to the performance of the models in the training data, in the cross-validation R-squared dropped 
to 0.1795 (MAE 5.27, MSE 41.13; Fig. 4D). Accordingly, the model including the variables was not better than a 
model using a constant number (MAE 5.35, MSE 50.27). This indicates that even with inclusion of the LC–MS/
MS based steroid profiles, the model-based boosting models generated from the training data cannot be extrapo-
lated to other data.
Discussion
Our study identified several single features before surgery that significantly correlated with adrenal cortisol 
production after surgery, and also correlated with ACTH stimulated cortisol after surgery in linear regression 
models. In particular, peak insulin secretion during OGTT before surgery correlated positively with ACTH 
stimulated cortisol after surgery. In addition, a greater suppression of glucocorticoids by dexamethasone before 
surgery also was associated with higher stimulated cortisol after surgery. Although age and sex affect circulating 
concentrations of some steroids, they had no impact in any correlation analysis. We also demonstrated that add-
ing information from steroid profiles determined by LC–MS/MS to conventional laboratory data could improve 
both, regression with ACTH stimulated cortisol after surgery and accuracy of classification of patients in the AI 
and AS groups in our data. However, when we used LOOCV to test the predictive capacity of various models 
established by our data, poor sensitivity was revealed. This indicates that—although additional variables from the 
LC–MS/MS profiles significantly improved the models in the training data—it is not possible to reliably predict 
adrenal function post-surgery based on the preoperative variables available in our study.
The positive association of insulin secretion during OGTT before surgery to ACTH stimulated cortisol post-
surgery was a consistent observation in our analyses. Insulin was also the most important variable in the regres-
sion model-based boosting analysis to predict adrenal status post-surgery in our training data (Fig. 4B) and had 
the largest influence in the linear regression model with the best cross validation (Table 1). ROC analysis showed 
that the AUC for insulin at 60 min and HbA1c were best to distinguish between sAI and AS groups (Supplemental 
Table S2). Co-secretion of glucocorticoids from aldosterone producing adenomas has been  demonstrated18. It is 
well-known that long-term exposure to excess glucocorticoids lead to the development of higher hepatic glucose 
production and decreased insulin-dependent glucose uptake into peripheral tissues, such as muscles—causing 
insulin resistance in a reactive hyperinsulinemic  state30, 31. However, in addition to their effect on glucose sensitiv-
ity, glucocorticoids are also known to acutely inhibit insulin secretion from pancreatic ß-cells30, 32. Furthermore, 
glucocorticoids decrease biosynthesis of insulin by reducing ATP/ADP ratio, while inducing ß-cells apoptosis 
directly and indirectly. Even in in vivo experiments with transgenic mice overexpressing the glucocorticoid 
receptor in ß-cells it was shown that initial insulin secretion decreased during a glucose  load33, 34. In humans, 
a large study from Japan showed an association between higher serum cortisol levels and decreased insulin 
secretion (lower HOMA-ß values) in a general  population35. These findings support that ß-cell function and 
Figure 3.  Plot of the true value and predicted value by linear regression model without (A) and with (B) LC–
MS/MS in cross validation.
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insulin secretion are reduced by elevated levels of glucocorticoids. Kamba et al. argue that—although high serum 
glucocorticoid concentrations are positively correlated with insulin resistance and with a compensatory increase 
of insulin secretion long term—acute suppression of ß-cell function may constitute for another aspect of gluco-
corticoid effects on glucose metabolism. In this setting, glucocorticoids cause suppression of insulin secretion. 
When glucocorticoid concentrations further increase over time to consistently elevated levels, insulin resistance 
develops. Therefore, insulin resistance as well as ß-cell dysfunction lead to impaired glucose metabolism and 
the development of  diabetes35. Our observation of lower peak insulin values during OGTT might reflect this 
aspect of the interplay between glucocorticoids and insulin secretion. In accordance, sAI patients tended to have 
lower HOMA-ß values, indicating suppressed ß-cell function. Thus, the lower 60 min. insulin concentrations 
during OGTT in the patients with higher glucocorticoids (which are at risk to develop AI post-surgery) do not 
contradict the general understanding on glucocorticoid effects on glucose/insulin homeostasis but might just 
reflect an early effect of glucocorticoids on the insulin secretion in our patient subgroup. This would explain 
why patients with lower peak insulin values could have experienced greater glucocorticoid exposure. This would 
be in line with our observation that dexamethasone suppression of glucocorticoids was less efficient, and that 
salivary cortisol at night was higher in the AI group. One could speculate about a mechanism where greater 
glucocorticoid exposure before surgery leads to a stronger suppression of glucocorticoid secretion from the 
contralateral adrenal, increasing the risk to develop transient adrenal insufficiency following the removal of the 
APA. Postoperative histopathological tumor sizes were also compared among the groups. PA patients with sAI 
and mAI tended to have slightly larger tumors, however not reaching statistical significance (median in mm: 
sAI: 17 (12.5; 20); mAI 15 (15; 25); AS 11 (8; 15), p = 0.096).
The use of LC–MS/MS based steroid profiles has contributed significantly to our understanding of adrenal 
 disease18, 36–40. Two recent  studies20, 41 have demonstrated that—by using slightly different LC–MS/MS based 
profiles of 15 steroids—it was possible to correctly classify the subtype of PA. Apart from allowing distinguish-
ing between BAH and APA, there were also associations of the steroid profiles obtained by LC–MS/MS with 
adenoma  genotype21. 18-hydroxycortisol and 18-oxocortisol have been shown to be helpful to distinguish BAH 
and  APA41. Unfortunately, our steroid profiles did not include these two steroids and limitations from sample 
volume did not allow a separate analysis.
Until today, no data have been published on the potential value of pre-surgical LC–MS/MS based steroid 
profiles to predict the occurrence of AI after surgery. In our study, the steroid profiles obtained at any of the 
Figure 4.  Plot of the true value and predicted value by model-based-boosting model without (A) and with (B) 
LC–MS/MS in training data. Importance of variables in model-based-boosting model (C). Plot of the true value 
and predicted value by model-based-boosting model with LC–MS/MS in cross validation (D).
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three different time points before surgery alone were not sufficient to establish associations with AI following 
surgery. We therefore combined the three steroid profiles together with 33 conventional parameters for feature 
selection, and subsequently compared models for correlation, classification and prediction without and with 
inclusion of the steroid profiles. We found that LC–MS/MS based steroid profiles can significantly improve the 
correlation models for ACTH stimulated cortisol post-surgery, and also help to correctly classify the AI and AS 
groups. Furthermore, inclusion of LC–MS/MS based steroid profiles reduced the error between predicted and 
true values in cross validation of the linear regression models.
However, although the model with LC–MS/MS data in classification achieved 100% accuracy in our training 
data, the majority of cases in the AI group was misclassified as AS in the cross validation. A discrepancy between 
the performance of models in the training data and the prediction in cross validation is frequently observed. A 
likely explanation is that such models tend to be over-fitted to the training data, and do not correctly embody 
the characters of the  data42. Consequently, predictive potency in the training data can be optimistically biased. 
Imbalance in the size of the groups can also dramatically decrease the power of statistical  methods43. In our case, 
the bigger group with 53 AS patients tends to dominate the classification models, and characters of the smaller 
group with 13 AI patients might not be taken up by the model.
Unfortunately, since the extended set of dynamic tests performed in our cohort is not part of clinical routine 
elsewhere, and patients undergoing adrenalectomy still are rare, it was impossible to get an independent new 
dataset for testing the models. However, we followed a standard approach to evaluate the performance of models 
by statistical techniques established for cross validation in the absence of independent data sets. The extent of 
the prediction in cross validation matching with the true values is the key criterion. Only when the prediction 
in cross validation is better than a featureless model, a model can be assumed to appropriately reflect existing 
relationships between the predictors and the target in the dataset. In addition to using all features, we also used 
two to seven of the top features only to build xgboost models to avoid overfitting. Indeed, using only the top four 
features in the xgboost, allowed correct classification of two more AI patients. However though slightly better, 
this is still not good enough to predict AI in a clinical setting. This finding supports our hypothesis that adding 
more variables can cause problems with overfitting. The fact that in our analysis a simplified linear model with 
the four significant variables was superior to a sophisticated model-based-boosting model with all the variables 
implies that including more variables must not necessarily lead to improved prediction but might just increase 
the noise in the data. Instead of just adding more variables, a guided selection of variables based on background 
knowledge about physiological relationships might be more appropriate to improve the models.
In summary our findings support the notion that glucocorticoid co-secretion from aldosterone-producing 
adenomas might be a risk factor for the development of adrenal insufficiency after adrenalectomy. Based on our 
findings, a prediction of the risk of AI during the pre-operative period still is not possible with enough reliability. 
Because of the elevated risk to develop transient adrenal insufficiency after unilateral adrenalectomy, we already 
do in our institution, and would generally recommend that clinicians should perform ACTH stimulation tests 
in all subjects with APAs after surgery, as AI is a potentially life-threatening condition. Better characterization 
of glucose metabolism before surgery could be important to understand the association. Furthermore, our study 
demonstrates that correlation- and classification models were improved by inclusion of data from LC–MS/MS 
based steroid profiles. In the training data, it was also possible to develop algorithms for accurate prediction of 
the adrenal function after surgery based on steroid profiles obtained before surgery. However, we also realized 
that our prediction models from the training data failed correct classification in cross-validation studies. This 
exemplifies that—while new technologies including the measurement of steroid profiles by LC–MS/MS allow 
increasing the number of variables—confirmation of the predictive value of adding more variables through 
cross-validation is crucial.
Materials and methods
Patients. In this study, we retrospectively analyzed blood samples obtained from 66 patients (30 males/36 
females, age range 24–73 years) who consented to be included in the prospective cohort of the German Conn’s 
registry and had a confirmed diagnosis of APA based on aldosterone-to-renin ratio (ARR), saline infusion testing 
(SIT) and underwent non-ACTH stimulated adrenal vein sampling (AVS) for subtyping. Clinical characteristics 
of the patients’ cohort as well as details of the screening and confirmatory tests have recently been  described17. 
From the original cohort of 100 patients, 66 underwent pre- and postoperative operative ACTH stimulation 
testing and were therefore included in the current analysis. Patients were classified as lateralized according to 
standard imaging and biochemical criteria (AVS: selectivity index > 2, lateralization index > 4) and underwent 
unilateral adrenalectomy at our institution from August 2014 to December 2018. All patients also received a 
preoperative 1 mg overnight dexamethasone suppression test (cut-off serum cortisol: > 1.8 µg/dL), measurement 
of late-night salivary cortisol (cut-off < 1.5 ng/mL) and 24-h collection of urinary free cortisol (cut-off < 83 µg/L). 
An oral glucose tolerance test (OGTT, 75 g) with insulin and glucose measurements at baseline and after 60 and 
120 min was performed in patients who did not have a diagnosis of diabetes mellitus type 1 or 2. In total, three 
patients had a history of diabetes mellitus type 2. All blood, urine and saliva samplings and dynamic tests were 
performed according to the standards of the German Conn  registry44. Informed consent was obtained from all 
study participants. The study was designed in agreement with the Declaration of Helsinki and approved by the 
Ethics Committee of the Medical Faculty of the Ludwig-Maximilians-University, Munich.
Definition of AI. Preoperative ACTH stimulation tests were performed one before adrenalectomy. Patients 
underwent postoperative testing on the day of discharge from the hospital (usually on the 4th or 5th day after 
surgery). Tests started at 8 AM after resting in a calm environment for at least 30 min. Serum cortisol levels were 
measured before and 30 min after intravenous application of 0.25 mg of 1‒24 ACTH (Synacthen). Pre- and 
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postoperatively, adrenal function was classified according to the outcome of the ACTH stimulation test. Since 
the patients’ treatment was based on our routine cortisol assay, we also used this assay for patient classification. 
Adrenal sufficiency (AS) was defined by ACTH stimulated serum cortisol ≥ 17 µg/dL, moderate adrenal insuf-
ficiency (mAI) between 13.5 and 17 µg/dL, and severe adrenal insufficiency (sAI) by stimulated serum corti-
sol ≤ 13.5 µg/dL. Postoperatively, 8 of the 66 patients were classified as sAI; 5 patients as mAI and 53 patients as 
AS. Since the group size was highly unbalanced, for all multiple-variable analyses we combined both, sAI and 
mAI, as the “AI group” (n = 13).
Variables. Overall, we included 78 patient variables obtained before surgery in our analysis (see Supple-
mental Table S1). The variables included anthropometric data (e.g. sex and age), parameters routinely obtained 
during physical examination (e.g. body mass index (BMI) and blood pressure (RR)), but also clinical chemistry 
and hormone assessments from the routine laboratory at baseline (e.g. cortisol and ACTH by immunoassay, 
potassium) and following dynamic tests (e.g. ACTH stimulated cortisol). In addition, we measured 15 adrenal 
steroids by LC–MS/MS from samples taken before surgery at baseline and after ACTH stimulation and after dex-
amethasone suppression. The 15 steroids were aldosterone, cortisol, cortisone, corticosterone, 11-deoxycortisol, 
21-deoxycortisol, dehydroepiandrosterone (DHEA), DHEA-sulfate (DHEAS), estradiol, testosterone, andros-
tenedione, 11-deoxycorticosterone, dihydrotestosterone, 17-hydroxyprogesterone and progesterone. HOMA-
IR (homeostatic model assessment–insulin resistance) was calculated using this equation: HOMA IR = fasting 
insulin (µU/mL) × fasting glucose (mg/dL)/405. HOMA-ß (homeostatic model assessment − ß-cell function) 
was calculated using this equation: HOMA-ß = 360 × fasting insulin (μU/mL)/(fasting glucose (mg/dL) − 63). 
Insulinogenic Index was calculated using this equation: IGI = Insulin at 60 min (μU/mL) – fasting insulin (μU/
mL)/(glucose at 60 min (mg/dL) – fasting glucose (mg/dL)).
Assay methods. For clinical workup, hormone concentrations were measured by routine immunoassay 
methods (active renin concentration, aldosterone, ACTH, cortisol all by Liaison, Diasorin, Saluggia, Italy). Ster-
oid measurements by LC–MS/MS were performed using a commercially available kit (Chromsystems, Darm-
stadt, Germany) according to the manufacturer’s instructions. In brief, solid phase extraction (SPE) with 500 µL 
of samples, calibrator solutions and quality control samples was performed. An internal standard mix (72,044, 
Chromsystems), containing deuterated analogs of all measured steroids, was added to the samples and each of 
the calibrator solutions and serum controls. The SPE procedure included two washing steps and an elution step 
with 500 µL elution buffer (72,033, Chromsystems). After SPE, the extract was evaporated to dryness and dis-
solved in reconstitution buffer (72,006, Chromsystems). The kit included serum calibrator set (72,038–72,039, 
Chromsystems) provided seven different concentration levels for the calibration and three different concentra-
tion levels of serum controls (0341–0347, Chromsystems). Additionally, three quality controls from an external 
supplier (Liquicheck, BioRad) were measured. The steroids were divided in two panels that were measured 
separately with an injection volume of 20 µL by gradient elution with mobile phase A (72,011, Chromsystems) 
and B (72,002, Chromsystems). Chromatographic separation and detection were performed with 1290 Infinity 
II HPLC System (Agilent, Waldbronn, Germany) coupled to a QTrap 6500 + tandem mass spectrometer (Sciex, 
Darmstadt, Germany). Electrospray ionization in positive and negative mode was used for ionization and meas-
urement mode was multi reaction monitoring. Data analysis was performed using Analyst 1.6.3 Software (Sciex, 
Darmstadt, Germany).
Statistical methods. Statistical analyses were conducted using R (version 3.6.1). R packages “MASS”, 
“tidyverse”, “glmnet”, “mice”, “DMwR”, “caret”, “randomForest”, “mlr”, “DataExplorer” and “corrplot” were 
required for analysis. Correlation coefficient was used to assess the correlation between variables obtained before 
surgery and ACTH stimulated cortisol after surgery. Analysis of variance or Kruskal–Wallis-Test was used to 
assess the difference between two groups. The equality of variance was tested by Levene’s test and Shapiro–Wilk 
test was used in test of normality. When required, data were logarithmically transformed. Model-based boosting 
was used in model fitting for regression. Gradient Tree boosting was used for classification. Leave-one-out cross 
validation (LOOCV) was integrated for the estimation of performance of models. Due to the small sample size 
we chose to use LOOCV instead of the commonly used k-fold cross validation methods. Permutation impor-
tance was used to calculate the importance of the  variables45. Missing data were imputed by K-nearest neighbor’s 
algorithm for multiple-variable analyses. Variables containing more than 20% missing values were excluded. 
This applied only to 15 steroid concentrations after dexamethasone suppression test measured by LC–MS/MS 
(details see Supplemental Table S1). Therefore, from the 78 variables, only 63 were available for multiple-variable 
analyses. Steroid hormone concentrations below the limit of quantification (LoQ) of the respective assay meth-
ods were replaced by 50% of the corresponding LoQ.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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